Focal One® brings the answer to all requirements for ideal focal therapy: accurate and MR-fused imaging, non-invasive surgical approach, precise and efficient therapeutic energy and treatment validation with post-treatment MRI.
Stereotactic Lithotripsy. "Freeline" ultrasound localization system. A user-friendly system to guarantee the best treatment efficacy. Available on the Sonolith® product range.
Meeting to Showcase EDAP’s Focal One® Robotic High Intensity Focused Ultrasound (HIFU) Platform for the Management of Prostate Cancer
Read more
EDAP TMS SA, a global leader in robotic energy-based therapies, today announced that the Company will host a webcast that will feature a live procedure broadcast of its Focal One HIFU as a potential treatment for ablating cancer tissue in patients who are diagnosed with prostate cancer. The webcast is scheduled for Tuesday, April 18th at 12:00 p.m. PDT (3:00 p.m. EDT).
Read more
EDAP TMS SA, a global leader in robotic energy-based therapies, announced today unaudited financial results for the fourth quarter and full-year 2022
Read more
EDAP TMS SA, a global leader in robotic energy-based therapies, today announced preliminary unaudited fourth quarter and full year 2022 revenue and other financial highlights.
Read more
As an alternative to standard radical therapies such as surgery and radiotherapy, EDAP TMS offers a non-invasive treatment based on High Intensity Focused Ultrasound (HIFU)...
As a world leader in extracorporeal lithotripsy for more than 40 years, EDAP TMS offers a complete range of non-invasive and minimally invasive solutions covering the full scope of Urinary Tract Stone Indications.